Commentary: Current Status of Gene Therapy for Spinal Muscular Atrophy is a research paper published in Frontiers in Cellular Neuroscience (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NINDS NIH HHS
Grant: R33 NS110960
National Institutes of Health
Grant: 5R01NS055925-11
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes
National Institutes of Health
Grant: 5R33NS110960-03
High-throughput Screen for Discovery of Ciliary Neurotrophic Factor (CNTF) Receptor Agonists for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Fields of Study
Keywords
Sustainable Development Goals